North America: Strategy

Workplace assessments require the same level of neutrality as workplace investigations to ensure meaningful organizational change. This article examines four critical areas where assessors must maintain objectivity: setting the mandate, messaging the process, selecting participants, and creating questions.

As law firms celebrate longevity and stability, they face a critical challenge that extends far beyond partner transitions: the impending retirement of long-tenured professional staff who hold decades of institutional knowledge. How can firms preserve this invaluable expertise while building a foundation for the next generation of legal professionals?

Daniel Waldman shares his insights on effective networking strategies within the legal industry, revealing how meaningful professional connections can lead to career opportunities. His article in Precedent Magazine explores the evolution from awkward networking attempts to building genuine relationships that create lasting value.

U.S. employers face mounting challenges in labor relations, from AI-driven workforce disruptions and multigenerational dynamics to aggressive union tactics and work stoppages. Littler's 2026 Labor Survey Report reveals how 665 executives across industries are adapting their employee engagement and labor relations strategies amid regulatory uncertainty and evolving workplace pressures.

Attorneys Steve Osborn and Jen Rubin explore how artificial intelligence is fundamentally reshaping the attorney-client relationship, from clients using AI to challenge legal advice to the critical risks of losing attorney-client privilege.

The numbers on enterprise AI projects moving to scale are not encouraging. According to S&P Global Market Intelligence, the average organization scrapped 46% of its AI proofs-of concept before they ever reached production. The share of companies abandoning most of their AI initiatives jumped from 17% to 42% in a single year.

The Commercial Industrial Brokers Society of Long Island convened industry professionals for their annual State of the Market panel discussion, examining current trends across office, industrial, retail, and investment sales sectors. Moderated by Real Estate and Economic Development Partner Peter Curry, the discussion revealed emerging market dynamics and evolving property uses that are shaping Long Island's commercial real estate landscape.

How will artificial intelligence reshape professional services careers, and what responsibilities do leaders have in ensuring their teams can thrive amid technological disruption? Drawing on personal experience and economic analysis, this exploration examines the strategic choices firms face as AI transforms routine tasks into opportunities for deeper client value and professional development.

Ankura's latest insights explore critical challenges across multiple sectors, from AI-driven cybersecurity threats targeting LLM infrastructure to the mounting healthcare workforce crisis in post-acute care. The collection examines how digital maturity drives financial performance, analyzes regulatory shifts in football finance, and tracks wealth management M&A activity amid evolving market dynamics.

The federal Opportunity Zone program has been made permanent through the One Big Beautiful Bill Act, introducing significant changes to tax deferral rules, census tract designations, and investment incentives. Understanding how Opportunity Zones 2.0 differs from the original program is critical for business owners, investors, and real estate developers planning transactions in 2026 and beyond.

The FSRA has introduced a new “Sub-Threshold Fund Manager” (STFM) category, designed to provide a proportionate regulatory approach for managers of smaller funds.

Partners from McDermott Will & Emery explore how European companies and investors can capitalize on China's rapidly growing biotech sector through innovative deal structures and strategic partnerships. The discussion examines emerging models like NewCo formations, equity investments, and co-development arrangements that enable European partners to access Chinese biotech innovation while leveraging Europe's clinical capabilities and regulatory expertise.